INMED PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, to be Paid, Year One
INMED PHARMACEUTICALS INC. (INM) had Lessee, Operating Lease, Liability, to be Paid, Year One of $31.32 thousand as of 2026-03-31, per its S-4 filed 2026-07-02.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-07-02
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $31.32K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $125.29K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $449.01K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $313.23K; Lessee, Operating Lease, Liability, to be Paid, Year One as first filed $475.09K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-03-31 | $31.32K S-4 · filed 2026-07-02 | |
| 2025-12-31 | $125.29K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $449.01K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $313.23K S-4 · filed 2026-07-02 | $475.09K 10-K · filed 2025-09-23 |
| 2025-03-31 | $469.37K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $469.19K 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $453.19K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $364.89K 10-K · filed 2024-09-30 | |
| 2023-12-31 | $361.38K 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $297.76K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $384.71K 10-K · filed 2023-09-29 | |
| 2021-06-30 | $98.73K 10-K · filed 2021-09-24 | |
| 2021-03-31 | $158.16K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $156.21K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $89.22K 10-Q · filed 2020-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |